Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

US Patent 12084452 · Granted Sep 10, 2024

Estimated economic value: $201,548,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosi2025
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative dise2025
Inhibitors of APOL1 and methods of using same2025
Substituted carbazole compounds2025
Modulators of alpha-1 antitrypsin2025
Substituted indole and indazole compounds2024
Apelin receptor agonists and methods of use2024
Inhibitors of protein tyrosine phosphatase, compositions, and methods of use2024
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified re2024
Bicyclic heteroaryl substituted compounds2024
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative dise2024